Rhiem K - Search Results

1

Modern day screening for Lynch syndrome in endometrial cancer: the KEM experience.

Pauly N, Baert T, Schmutzler R, du Bois A, Schneider S, Rhiem K, Schömig-Markiefka B, Siemanowski J, Heikaus S, Traut A, Heitz F, Prader S, Ehmann S, Harter P, Ataseven B. Pauly N, et al. Among authors: rhiem k. Arch Gynecol Obstet. 2021 Oct;304(4):975-984. doi: 10.1007/s00404-021-06006-w. Epub 2021 Mar 12. Arch Gynecol Obstet. 2021. PMID: 33710393

2

Familial ovarian dysgerminomas (Swyer syndrome) in females associated with 46 XY-karyotype.

Kempe A, Engels H, Schubert R, Meindl A, van der Ven K, Plath H, Rhiem K, Schwanitz G, Schmutzler RK. Kempe A, et al. Among authors: rhiem k. Gynecol Endocrinol. 2002 Apr;16(2):107-11. Gynecol Endocrinol. 2002. PMID: 12012620

3

Chromosomal region 15q21.1 is a frequent target of allelic imbalance in advanced breast carcinomas.

Rhiem K, Klein A, Münch M, Kreutzfeld R, Ramser J, Wardelmann E, Schackert G, Von Deimling A, Wiestler OD, Schmutzler RK. Rhiem K, et al. Int J Cancer. 2003 Aug 10;106(1):74-7. doi: 10.1002/ijc.11169. Int J Cancer. 2003. PMID: 12794759 Free article.

4

BRCA1-associated breast carcinomas frequently present with benign sonographic features.

Rhiem K, Flucke U, Schmutzler RK. Rhiem K, et al. AJR Am J Roentgenol. 2006 May;186(5):E11-2; author reply E12-3. doi: 10.2214/AJR.06.5041. AJR Am J Roentgenol. 2006. PMID: 16632699 No abstract available.

5

Screening for ovarian cancer by transvaginal ultrasound and serum CA125 measurement in women with a familial predisposition: a prospective cohort study.

Bosse K, Rhiem K, Wappenschmidt B, Hellmich M, Madeja M, Ortmann M, Mallmann P, Schmutzler R. Bosse K, et al. Among authors: rhiem k. Gynecol Oncol. 2006 Dec;103(3):1077-82. doi: 10.1016/j.ygyno.2006.06.032. Epub 2006 Aug 9. Gynecol Oncol. 2006. PMID: 16904167

6

Outcome of a structured surveillance programme in women with a familial predisposition for breast cancer.

Schmutzler RK, Rhiem K, Breuer P, Wardelmann E, Lehnert M, Coburger S, Wappenschmidt B. Schmutzler RK, et al. Among authors: rhiem k. Eur J Cancer Prev. 2006 Dec;15(6):483-9. doi: 10.1097/01.cej.0000220624.70234.14. Eur J Cancer Prev. 2006. PMID: 17106326

7

Association of the BRCA1 missense variant R1699W with a malignant phyllodes tumor of the breast.

Rhiem K, Flucke U, Engel C, Wappenschmidt B, Reinecke-Lüthge A, Büttner R, Schmutzler RK. Rhiem K, et al. Cancer Genet Cytogenet. 2007 Jul 1;176(1):76-9. doi: 10.1016/j.cancergencyto.2007.03.006. Cancer Genet Cytogenet. 2007. PMID: 17574969

8

Platinum sensitivity in a BRCA1 mutation carrier with advanced breast cancer.

Rhiem K, Wappenschmidt B, Bosse K, Köppler H, Tutt AN, Schmutzler RK. Rhiem K, et al. Clin Oncol (R Coll Radiol). 2009 Aug;21(6):448-50. doi: 10.1016/j.clon.2009.01.006. Epub 2009 Feb 26. Clin Oncol (R Coll Radiol). 2009. PMID: 19249193

9

Contralateral breast cancer risk in BRCA1 and BRCA2 mutation carriers.

Graeser MK, Engel C, Rhiem K, Gadzicki D, Bick U, Kast K, Froster UG, Schlehe B, Bechtold A, Arnold N, Preisler-Adams S, Nestle-Kraemling C, Zaino M, Loeffler M, Kiechle M, Meindl A, Varga D, Schmutzler RK. Graeser MK, et al. Among authors: rhiem k. J Clin Oncol. 2009 Dec 10;27(35):5887-92. doi: 10.1200/JCO.2008.19.9430. Epub 2009 Oct 26. J Clin Oncol. 2009. PMID: 19858402

10

Risk-reducing salpingo-oophorectomy in BRCA1 and BRCA2 mutation carriers.

Rhiem K, Foth D, Wappenschmidt B, Gevensleben H, Büttner R, Ulrich U, Schmutzler RK. Rhiem K, et al. Arch Gynecol Obstet. 2011 Mar;283(3):623-7. doi: 10.1007/s00404-010-1476-3. Epub 2010 Apr 29. Arch Gynecol Obstet. 2011. PMID: 20428881

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

179 results

Search Page